Response to the Letter to the Editor Entitled “Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits”
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024925003523 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849708343992516608 |
|---|---|
| author | M. Costes-Albrespic N. Alencar de Pinho Z.A. Massy S. Liabeuf |
| author_facet | M. Costes-Albrespic N. Alencar de Pinho Z.A. Massy S. Liabeuf |
| author_sort | M. Costes-Albrespic |
| collection | DOAJ |
| format | Article |
| id | doaj-art-fa97ca780e3e45cc9036db65db11aab1 |
| institution | DOAJ |
| issn | 2468-0249 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-fa97ca780e3e45cc9036db65db11aab12025-08-20T03:15:42ZengElsevierKidney International Reports2468-02492025-08-011082877287810.1016/j.ekir.2025.05.048Response to the Letter to the Editor Entitled “Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits”M. Costes-Albrespic0N. Alencar de Pinho1Z.A. Massy2S. Liabeuf3Clinical Epidemiology Team, Centre for Research in Epidemiology and Population Health, Inserm U1018, Paris-Saclay University, Versailles Saint-Quentin University, Villejuif, FranceClinical Epidemiology Team, Centre for Research in Epidemiology and Population Health, Inserm U1018, Paris-Saclay University, Versailles Saint-Quentin University, Villejuif, France; Correspondence: Natalia Alencar de Pinho, Hôpital Paul Brousse, 16, avenue Paul Vaillant Couturier, F-94807 Villejuif, France.Clinical Epidemiology Team, Centre for Research in Epidemiology and Population Health, Inserm U1018, Paris-Saclay University, Versailles Saint-Quentin University, Villejuif, France; Association pour l'Utilisation du Rein Artificiel, Paris, France; Nephrology Department, Ambroise Paré University Hospital, APHP, Boulogne-Billancourt, ParisPharmaco-epidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Medical Centre, Amiens, France; MP3CV Laboratory, Jules Verne University of Picardie, Amiens, Francehttp://www.sciencedirect.com/science/article/pii/S2468024925003523 |
| spellingShingle | M. Costes-Albrespic N. Alencar de Pinho Z.A. Massy S. Liabeuf Response to the Letter to the Editor Entitled “Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits” Kidney International Reports |
| title | Response to the Letter to the Editor Entitled “Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits” |
| title_full | Response to the Letter to the Editor Entitled “Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits” |
| title_fullStr | Response to the Letter to the Editor Entitled “Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits” |
| title_full_unstemmed | Response to the Letter to the Editor Entitled “Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits” |
| title_short | Response to the Letter to the Editor Entitled “Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits” |
| title_sort | response to the letter to the editor entitled optimizing furosemide use in advanced ckd balancing risks and benefits |
| url | http://www.sciencedirect.com/science/article/pii/S2468024925003523 |
| work_keys_str_mv | AT mcostesalbrespic responsetothelettertotheeditorentitledoptimizingfurosemideuseinadvancedckdbalancingrisksandbenefits AT nalencardepinho responsetothelettertotheeditorentitledoptimizingfurosemideuseinadvancedckdbalancingrisksandbenefits AT zamassy responsetothelettertotheeditorentitledoptimizingfurosemideuseinadvancedckdbalancingrisksandbenefits AT sliabeuf responsetothelettertotheeditorentitledoptimizingfurosemideuseinadvancedckdbalancingrisksandbenefits |